Product Images Buprenorphine And Naloxone

Each tablet contains Buprenorphine 216mg and Naloxone 0.61mg as a sublingual Tablet used as per Product Information for medical purposes, accompanied by a Medication Guide for pharmacist use only. Produced by Ethypharm S.A in France and distributed in the US by Akom Operating Company LLC. The tablets should be stored at 20° to 25°C (68° to 77°F) in a controlled room temperature setting, and the cap should be kept out of reach of children to avoid accidental ingestion. If children consume the drug, immediate medical care is necessary. No other useful information is available in the given text.*

This is a description of a medication which is a combination of buprenorphine HCI and naloxone HCI dihydrate. The tablets are manufactured by Ethypharm S.A. in France and distributed by Akorn Operating Company LLC in Gurnee, Illinois. Each tablet contains 8.64mg of buprenorphine and 2.44mg of naloxone. The recommended dosage and storage information is provided in the insert included with the product. The medication is dispensed with a medication guide which includes important safety information. The medication is prescription-only and requires medical care in the event of accidental ingestion by children.*